The global bioinformatics market was valued at USD 20.34 billion in 2025 and is projected to reach USD 64.59 billion by 2034, growing at a CAGR of 13.7% from 2026 to 2034. North America led the market in 2025, while Europe is expected to register the fastest growth.

• Market Size (2025): USD 20.34 billion

• Market Size (2026): USD 23.13 billion

• CAGR (Forecast Period): 13.7%

• Forecast Year: 2034

• Projected Market Size: USD 64.59 billion

• Dominant Region: North America

• Fastest Growing Region: Europe

Market Overview

Bioinformatics combines biology, computing, and data science to manage and analyze complex biological information. Its use across genomics, drug discovery, molecular diagnostics, clinical research, and personalized medicine is supporting market expansion.

Growth Drivers

The growing scale of genomic and pharmaceutical datasets is increasing the need for advanced computational analysis. Cloud infrastructure is also enabling organizations to process large biological datasets without investing heavily in equivalent on-premise systems.

Challenges

High infrastructure and software costs can limit adoption among smaller laboratories and research institutions. A shortage of professionals with expertise in computational biology, genomics, and data science also creates implementation challenges.

Opportunities

Clinical diagnostics and microbiome research are creating opportunities for bioinformatics providers. Sequencing companies, diagnostic laboratories, biotechnology firms, and specialized software developers can expand genomic interpretation, microbial profiling, and biological-data analysis solutions.

Segment Analysis

Bioinformatics platforms led the technology and service segment with a 42.3% share in 2025, while bioinformatics services are expected to record a 14.1% CAGR through 2034. Genomics represented the largest application segment at 27.5%, and medical bioinformatics accounted for 46.2% of the sector segment.

Regional Analysis

North America held 39.5% of the global market in 2025, supported by strong genomics research, pharmaceutical activity, and advanced computational infrastructure. Europe is projected to grow at a 14.6% CAGR, supported by genomic medicine and healthcare initiatives.

Asia Pacific accounted for 22.4% of the market in 2025, with genomic programs and biotechnology investments across Japan, China, and India supporting regional development.

Competitive Landscape

The market is moderately fragmented, with companies competing through analytical platforms, AI capabilities, interoperability, scalability, cybersecurity, and specialized biological-data solutions.

• Illumina

• Agilent Technologies

• Quest Diagnostics

• Bruker Daltonics

• Biomax Informatics

• Life Technologies

• Sanofi

• BioNTech

• BioInvent

• Juvenescence

Recent Developments

Large-scale genomic and multi-omics datasets are expanding the foundation for bioinformatics applications. In 2026, the NIH All of Us Research Program provided data from more than 747,000 participants, including over 535,000 whole-genome sequences and nearly 482,000 linked electronic health records.

Future Outlook

AI-driven analysis, multi-omics integration, cloud computing, genomic interpretation, and computational drug discovery are expected to remain key areas of bioinformatics development. The increasing volume and complexity of biological data should support continued adoption across healthcare, pharmaceuticals, biotechnology, and research.

Click to Read the Complete Insights & Report: https://straitsresearch.com/report/bioinformatics-market

About Straits Research

Straits Research is a global market intelligence and consulting company providing market research reports, industry analysis, strategic insights, and consulting services across diverse industries. Its research supports businesses and organizations in understanding market trends, opportunities, competitive landscapes, and emerging developments.